Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -334,259 | -226,219 | -115,361 | -317,418 | -227,876 |
| Depreciation Amortization | 81 | -74 | -114 | -1,931 | -1,545 |
| Accounts payable and accrued liabilities | 17,714 | -756 | -8,601 | -8,955 | -7,964 |
| Other Working Capital | 7,907 | 2,039 | -3,602 | -19,491 | -14,406 |
| Other Operating Activity | 17,182 | 24,414 | 21,785 | 55,426 | 43,757 |
| Operating Cash Flow | $-291,375 | $-200,596 | $-105,893 | $-292,369 | $-208,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -153,823 | -106,903 | -65,970 | -317,443 | -264,729 |
| PPE Investments | -1,436 | -1,041 | -981 | -2,376 | -1,301 |
| Purchase Of Investment | 135,847 | 107,708 | 65,439 | 105,180 | 76,215 |
| Sale Of Investment | 8,469 | 8,468 | 2,970 | 10,563 | 1,749 |
| Other Investing Activity | -18,790 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-29,733 | $8,232 | $1,458 | $-204,076 | $-188,066 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 98,802 | 98,802 | N/A | N/A | N/A |
| Common Stock Issued | 361,089 | 143,213 | 141,241 | 809,895 | 806,259 |
| Other Financing Activity | -549 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $459,342 | $242,015 | $141,241 | $809,895 | $806,259 |
| Beginning Cash Position | 437,391 | 437,391 | 437,391 | 123,941 | 123,941 |
| End Cash Position | 575,625 | 487,042 | 474,197 | 437,391 | 534,100 |
| Net Cash Flow | $138,234 | $49,651 | $36,806 | $313,450 | $410,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -291,375 | -200,596 | -105,893 | -292,369 | -208,034 |
| Capital Expenditure | -1,436 | -1,041 | -981 | -2,376 | -1,301 |
| Free Cash Flow | -292,811 | -201,637 | -106,874 | -294,745 | -209,335 |